aminoacetonitrile has been researched along with Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gobec, S; Kos, J; Mirković, B; Mitrović, A; Sosič, I | 1 |
Brandl, MB; Chang, J; Cui, K; Jin, G; Li, F; Mao, Y; Nie, F; Rodriguez, A; Wang, L; Wong, ST; Xue, Z; Zhao, H | 1 |
2 other study(ies) available for aminoacetonitrile and Breast Neoplasms
Article | Year |
---|---|
Inhibition of endopeptidase and exopeptidase activity of cathepsin B impairs extracellular matrix degradation and tumour invasion.
Topics: Aminoacetonitrile; Breast Neoplasms; Cathepsin B; Cell Survival; Dose-Response Relationship, Drug; Extracellular Matrix; Female; Humans; Molecular Structure; Neoplasm Invasiveness; Nitroquinolines; Piperidines; Protease Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |
The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models.
Topics: Aminoacetonitrile; Animals; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Neovascularization, Pathologic; Protein Kinase Inhibitors; Sirolimus; TOR Serine-Threonine Kinases | 2012 |